AAAAAA
Results:
1-21
|
Results: 21
Authors:
Lilford, RJ
Djulbegovic, B
Citation: Rj. Lilford et B. Djulbegovic, Declaration of Helsinki should be strengthened - Equipoise is essential principle of human experimentation, BR MED J, 322(7281), 2001, pp. 299-300
Uncertainty about clinical equipoise - Equipoise and uncertainty principleare not mutually exclusive
Authors:
Lilford, RJ
Djulbegovic, B
Citation: Rj. Lilford et B. Djulbegovic, Uncertainty about clinical equipoise - Equipoise and uncertainty principleare not mutually exclusive, BR MED J, 322(7289), 2001, pp. 795-795
Authors:
Djulbegovic, B
Adams, JR
Lyman, GH
Lacevic, M
Hozo, I
Greenwich, M
Bennett, CL
Citation: B. Djulbegovic et al., Evaluation and appraisal of randomized controlled trials in myeloma, ANN ONCOL, 12(11), 2001, pp. 1611-1617
Authors:
Clark, O
Clark, L
Djulbegovic, B
Citation: O. Clark et al., Is clinical research still too haphazard?, LANCET, 358(9293), 2001, pp. 1648-1648
Authors:
Djulbegovic, B
Clarke, M
Citation: B. Djulbegovic et M. Clarke, Ethical issues in the reporting of clinical trials, J AM MED A, 286(13), 2001, pp. 1577-1577
Authors:
Djulbegovic, B
Clarke, M
Citation: B. Djulbegovic et M. Clarke, Scientific and ethical issues in equivalence trials, J AM MED A, 285(9), 2001, pp. 1206-1208
Authors:
Djulbegovic, B
Clarke, M
Citation: B. Djulbegovic et M. Clarke, Informing patients of uncertainty in clinical trials - Reply, J AM MED A, 285(21), 2001, pp. 2714-2714
Authors:
Djulbegovic, B
Cohen, Y
Citation: B. Djulbegovic et Y. Cohen, The natural history of refractory idiopathic thrombocytopenic purpura, BLOOD, 98(7), 2001, pp. 2282-2282
Authors:
Djulbegovic, B
Citation: B. Djulbegovic, Placebo-controlled trials, ANN INT MED, 135(1), 2001, pp. 62-63
Authors:
Djulbegovic, B
Morris, L
Lyman, GH
Citation: B. Djulbegovic et al., Evidentiary challenges to evidence-based medicine, J EVAL CL P, 6(2), 2000, pp. 99-109
Authors:
Knox, KS
Adams, JR
Djulbegovic, B
Stinson, TJ
Tomori, C
Bennett, CL
Citation: Ks. Knox et al., Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology, ANN ONCOL, 11(12), 2000, pp. 1591-1595
Authors:
Djulbegovic, B
Bennett, CL
Adams, JR
Lyman, GH
Citation: B. Djulbegovic et al., Industry-sponsored research - Reply, LANCET, 356(9248), 2000, pp. 2194-2194
Authors:
Djulbegovic, B
Lacevic, M
Cantor, A
Fields, KK
Bennett, CL
Adams, JR
Kuderer, NM
Lyman, GH
Citation: B. Djulbegovic et al., The uncertainty principle and industry-sponsored research, LANCET, 356(9230), 2000, pp. 635-638
Authors:
Djulbegovic, B
Citation: B. Djulbegovic, Acquired anaemias and polycythaemia, LANCET, 356(9229), 2000, pp. 596-596
Authors:
Cohen, YC
Djulbegovic, B
Shamai-Lubovitz, O
Mozes, B
Citation: Yc. Cohen et al., The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts, ARCH IN MED, 160(11), 2000, pp. 1630-1638
Authors:
Djulbegovic, B
Lyman, GH
Hozo, I
Citation: B. Djulbegovic et al., Talking about treatment, ANN INT MED, 132(1), 2000, pp. 94-94
Authors:
Djulbegovic, B
Hozo, I
Citation: B. Djulbegovic et I. Hozo, Computer program for the diagnosis and treatment of polycythemia rubra vera (vol 16, pg 83, 1999), M D COMPUT, 16(5), 1999, pp. 10-10
Authors:
Djulbegovic, B
Hozo, I
Citation: B. Djulbegovic et I. Hozo, Computer program for the diagnosis and treatment of polycythemia rubra vera, M D COMPUT, 16(1), 1999, pp. 83-89
Authors:
Djulbegovic, B
Hozo, I
Schwartz, A
McMasters, KM
Citation: B. Djulbegovic et al., Acceptable regret in medical decision making, MED HYPOTH, 53(3), 1999, pp. 253-259
Authors:
Hozo, I
Djulbegovic, B
Citation: I. Hozo et B. Djulbegovic, Using the Internet to calculate clinical action thresholds, COMPUT BIOM, 32(2), 1999, pp. 168-185
Authors:
Djulbegovic, B
Loughran, TP
Hornung, CA
Kloecker, G
Efthimiadis, EN
Hadley, TJ
Englert, J
Hoskins, M
Goldsmith, GH
Citation: B. Djulbegovic et al., The quality of medical evidence in hematology-oncology, AM J MED, 106(2), 1999, pp. 198-205
Risultati:
1-21
|